Phase II sbir- rapid, automated, multiplexed omics platform

Active Definitive Contract Awarded Last action

Contract number
HT942525CE052
Awardee
Awarding agency
Obligated
$1,299,987

Award facts

Opportunity
  • HQ003420RBDST Solicitation number
Contract value 100% obligated
$1,299,987.38 Current and potential, with all options
Completion date 46% complete
Current and potential, with all options
Contracting staff
Set-aside
Total Small Business
Competition
Full and Open Competition after exclusion of sources · 1 offer Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Lowell, MA 01852, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00001 · Rapid, automated, multiplexed omics platform $0
Original award $1,299,987

About this award

The Defense Health Agency awarded a $1,299,987.38 firm fixed price definitive contract to Emergingdx Inc. for Phase II SBIR development of a rapid, automated, multiplexed omics platform on September 26, 2025, under a total small business set-aside.

Emergingdx Inc. is a small business headquartered in Lowell, Massachusetts, specializing in advanced diagnostic and biosensor technologies. Work will be performed in Lowell, MA. The contract extends to January 25, 2028.

Quick answers

Who was awarded contract HT942525CE052?

HT942525CE052 was awarded to Emergingdx Inc. by Defense Health Agency (Department of Defense) on September 26, 2025.

How much is contract HT942525CE052 worth?

The government has obligated $1,299,987 on HT942525CE052.

Was contract HT942525CE052 competed?

The extent of competition for HT942525CE052 was full and open competition after exclusion of sources. The government received 1 offer. It was set aside: Total Small Business.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award